Rasmussen, Annette Vangaa
Jensen, Rigmor Hoejland
Karlsson, Leena Eklund
Mose, Louise Schlosser http://orcid.org/0000-0002-6898-4611
Funding for this research was provided by:
H. Lundbeck A/S (421538)
Article History
Received: 16 August 2022
Accepted: 16 February 2023
First Online: 24 February 2023
Declarations
:
: The study is registered at The Region of Southern Denmark (21/52885). According to The Regional Ethical Committee and law, no additional ethical approval was relevant (20212000-145). A written informed consent is obtained from all participants before inclusion in the study. All participants are informed that they can withdraw from the study at any time without giving a reason.
: Not applicable.
: The study is funded with a research grant from the commercial organization H. Lundbeck A/S. L.E.K and L.S.M have declared no conflict of interests. A.V. R has received honoraria from Lundbeck and Eli Lilly for Advisory Boards and written compendium and R.H. J has received honoraria for lectures and patient leaflets from MSD, Berlin-Chemie Menarini, ATI, and Pfizer; participated in medical advisory boards for ATI and Electrocore and conducted clinical trials for Eli-Lilly and ATI.